SKN | Has Johnson & Johnson’s Rally Run Ahead of Its Fundamentals After a 60% Gain?
Market Reviews Johnson & Johnson has re-emerged as a market standout after a powerful rally that has pushed its share price close to $240. For a company long regarded as a defensive healthcare anchor rather than a momentum name, the recent performance has forced investors to reassess not just the company’s prospects, but whether the stock’s valuation […]